US approved drug for malaria and leishmaniesis in US military and civilian personnel (Research, Development, Test and Evaluation - Army)
FY 2008
State
Cost $3,400,000.00
Status NBR
Chamber S
Appropriation DEF
House
Senate Cochran, Lott
Return to search page.